Literature DB >> 24981832

CNS demyelinating disorder with mixed features of neuromyelitis optica and multiple sclerosis in HIV-1 infection. Case report and literature review.

Silvia R Delgado1, Janice Maldonado, Kottil W Rammohan.   

Abstract

An African-American male presented with bilateral visual impairment, gait difficulties, and bladder and bowel incontinence raising concerns for multiple sclerosis (MS) or neuromyelitis optica (NMO). He was identified to be HIV-1 infected with high viral load and low CD4+ counts. Magnetic resonance imaging (MRI) of the brain was abnormal, but atypical for MS. MRI of the cervical and thoracic spinal cord showed multiple areas of myelitis with a longitudinally extensive thoracic transverse myelitis that showed enhancement with gadolinium suggestive of NMO. Cerebrospinal fluid showed oligoclonal IgG bands but did not show reactivity to aquaporin 4. Patient underwent treatment for the acute exacerbation with intravenous corticosteroids and treatment of the HIV infection with highly active antiretroviral therapy (HAART). A year later, his viral load was <20 copies/ml and CD4+ counts were normal. Vision did not significantly improve, but his ambulation improved from a near total non-ambulatory state to ambulating without aids and resolution of the bladder and bowel incontinence. A demyelinating disorder of the central nervous system (CNS) like MS or NMO has been previously reported in the context of HIV infection. The remarkable improvement of symptoms has also been previously reported with HAART, and these observations have led to clinical trials of MS with HAART therapy in the absence of HIV infection. We reviewed the few cases of CNS demyelinating disorders with HIV infection reported in the literature and speculate on the mechanisms of pathogenesis.

Entities:  

Mesh:

Year:  2014        PMID: 24981832     DOI: 10.1007/s13365-014-0260-8

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  15 in total

1.  Devic's neuromyelitis optica and HIV-1 infection.

Authors:  P Blanche; E Diaz; B Gombert; D Sicard; O Rivoal; A Brezin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-06       Impact factor: 10.154

2.  Acute disseminated encephalomyelitis as manifestation of primary HIV infection.

Authors:  P Narciso; S Galgani; B Del Grosso; M De Marco; A De Santis; P Balestra; V Ciapparoni; V Tozzi
Journal:  Neurology       Date:  2001-10-23       Impact factor: 9.910

3.  Could antiretroviral drugs be effective in multiple sclerosis? A case report.

Authors:  H Maruszak; B J Brew; G Giovannoni; J Gold
Journal:  Eur J Neurol       Date:  2011-09       Impact factor: 6.089

4.  Mechanism of hypergammaglobulinemia by HIV infection: circulating memory B-cell reduction with plasmacytosis.

Authors:  H Nagase; K Agematsu; K Kitano; M Takamoto; Y Okubo; A Komiyama; K Sugane
Journal:  Clin Immunol       Date:  2001-08       Impact factor: 3.969

5.  Molecular mimicry between the human immunodeficiency virus type 1 gp120 V3 loop and human brain proteins.

Authors:  J R Trujillo; M F McLane; T H Lee; M Essex
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

Review 6.  B cells and antibodies in multiple sclerosis pathogenesis and therapy.

Authors:  Markus Krumbholz; Tobias Derfuss; Reinhard Hohlfeld; Edgar Meinl
Journal:  Nat Rev Neurol       Date:  2012-10-09       Impact factor: 42.937

7.  Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.

Authors:  R A Farrell; D Antony; G R Wall; D A Clark; L Fisniku; J Swanton; Z Khaleeli; K Schmierer; D H Miller; G Giovannoni
Journal:  Neurology       Date:  2009-05-20       Impact factor: 9.910

Review 8.  Human T-lymphotropic virus type II and neurological disease.

Authors:  Abelardo Araujo; William W Hall
Journal:  Ann Neurol       Date:  2004-07       Impact factor: 10.422

9.  Multiple sclerosis-like illness occurring with human immunodeficiency virus infection.

Authors:  J R Berger; W A Sheremata; L Resnick; S Atherton; M A Fletcher; M Norenberg
Journal:  Neurology       Date:  1989-03       Impact factor: 9.910

10.  Intrathecal synthesis of anti-myelin basic protein IgG in HIV-1+ patients.

Authors:  D Maimone; P Annunziata; C Cioni; A Leonardi; G C Guazzi
Journal:  Acta Neurol Scand       Date:  1994-10       Impact factor: 3.209

View more
  8 in total

1.  HIV and decreased risk of multiple sclerosis: role of low CD4+ lymphocyte count and male prevalence.

Authors:  Tatiana Koudriavtseva; Domenico Plantone; Chiara Mandoj; Diana Giannarelli; Alessandra Latini; Manuela Colafigli; Elisabetta Trento; Paola Cordiali-Fei; Fulvia Pimpinelli
Journal:  J Neurovirol       Date:  2016-07-18       Impact factor: 2.643

2.  Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man.

Authors:  Joshua Chalkley; Joseph R Berger
Journal:  J Neurovirol       Date:  2014-11-01       Impact factor: 2.643

3.  Multiple sclerosis and HIV-1 infection: case report of a HIV controller.

Authors:  Jerome H Chin
Journal:  J Neurovirol       Date:  2015-03-24       Impact factor: 2.643

4.  Do Antiretroviral Drugs Protect From Multiple Sclerosis by Inhibiting Expression of MS-Associated Retrovirus?

Authors:  Elena Morandi; Radu Tanasescu; Rachael E Tarlinton; Dumitru Constantin-Teodosiu; Bruno Gran
Journal:  Front Immunol       Date:  2019-01-22       Impact factor: 7.561

Review 5.  Viruses and endogenous retroviruses in multiple sclerosis: From correlation to causation.

Authors:  A-F A Mentis; E Dardiotis; N Grigoriadis; E Petinaki; G M Hadjigeorgiou
Journal:  Acta Neurol Scand       Date:  2017-05-23       Impact factor: 3.209

Review 6.  Human immunodeficiency virus and multiple sclerosis: a review of the literature.

Authors:  Maria-Ioanna Stefanou; Markus Krumbholz; Ulf Ziemann; Markus C Kowarik
Journal:  Neurol Res Pract       Date:  2019-08-20

Review 7.  Differential diagnosis of neuromyelitis optica spectrum disorders.

Authors:  Sung-Min Kim; Seong-Joon Kim; Haeng Jin Lee; Hiroshi Kuroda; Jacqueline Palace; Kazuo Fujihara
Journal:  Ther Adv Neurol Disord       Date:  2017-05-24       Impact factor: 6.570

8.  Neurological manifestations, laboratory and neuroimaging features in HIV-infected patients.

Authors:  Hai Chen; Fangju Lin; Shimeng Liu; Yuwei Da; Dongmei Guo
Journal:  Neurosciences (Riyadh)       Date:  2017-10       Impact factor: 0.906

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.